ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,817Medicare Part D Prescriptions Filled, Including Refills

Rank: 561 out of 4623

$502K Total Retail Price of All Prescriptions

Rank: 739 out of 4623

651 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

21% of this provider’s 651 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 7,676 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 650 529 1 2
AMLODIPINE BESYLATE 469 369 2 5
METFORMIN HCL 415 338 3 6
LISINOPRIL 392 312 4 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 292 255 5 19
OMEPRAZOLE 275 231 6 7
LEVOTHYROXINE SODIUM 274 230 7 1
HYDROCODONE-ACETAMINOPHEN 244 96 S3 8 3
FUROSEMIDE 182 133 9 8
GABAPENTIN 172 132 10 16
HYDROCHLOROTHIAZIDE 147 116 11 10
LOSARTAN-HYDROCHLOROTHIAZIDE 119 97 12 46
METOPROLOL SUCCINATE 119 100 12 13
SULFAMETHOXAZOLE-TRIMETHOPRIM 109 75 14 68
GLIMEPIRIDE 107 79 15 38
ATORVASTATIN CALCIUM 106 83 16 12
CARVEDILOL 100 78 17 25
LOSARTAN POTASSIUM 98 98 18 21
ATENOLOL 97 91 19 28
CITALOPRAM HBR 96 68 20 23
TRAZODONE HCL 94 54 21 42
TAMSULOSIN HCL 92 71 22 29
METOPROLOL TARTRATE 91 82 23 9
CLOPIDOGREL 90 74 24 31
ZOLPIDEM TARTRATE 88 67 25 18
AZITHROMYCIN 86 66 26 33
PROAIR HFA 75 61 27 64
METHYLPREDNISOLONE 75 60 27 103
CELEBREX 75 36 27 89
DIOVAN HCT 73 52 30 67
NEXIUM 72 55 31 17
PRAVASTATIN SODIUM 71 67 32 11
NAPROXEN 69 48 33 63
WARFARIN SODIUM 65 59 34 24
CLONIDINE HCL 64 61 35 40
TRAMADOL HCL 64 46 35 15
ADVAIR DISKUS 64 51 35 62
PLAVIX 61 53 38 45
GLIPIZIDE 60 55 39 49
CIPROFLOXACIN HCL 60 54 39 43
CYMBALTA 59 30 41 48
SERTRALINE HCL 57 57 42 26
LOVASTATIN 57 57 42 34
GLYBURIDE 56 40 R 44 59
IBUPROFEN 56 50 44 65
CYCLOBENZAPRINE HCL 55 30 R 46 53
LANTUS 54 50 47 44
POTASSIUM CHLORIDE 52 37 48 14
CEFUROXIME 51 38 49 152
KLOR-CON M20 50 44 50 102
PREMARIN 50 37 R 50 140
PAROXETINE HCL 50 36 50 78
MELOXICAM 50 45 50 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 13, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.